British Journal of Cancer· 2013Q1

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

Boikanyo Makubate, Peter T. Donnan, J A Dewar, A.M. Thompson et al.

304citations
Q1SCImago
2013year

Short summary

Low adherence (<80%) to adjuvant endocrine therapy (tamoxifen or AIs) for breast cancer is associated with a 20% increased risk of all-cause mortality (HR=1.20, P=0.019).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Family Practice

Family PracticeMedicine